Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin.

Por Ellis, V, Danø, K
Publicado em 1993

Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.

Por Pyke, C., Ralfkiaer, E., Tryggvason, K., Danø, K.
Publicado em 1993

Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line...

Por Lund, L R, Ellis, V, Rønne, E, Pyke, C, Danø, K
Publicado em 1995

Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.

Por Cubellis, M V, Andreasen, P, Ragno, P, Mayer, M, Danø, K, Blasi, F
Publicado em 1989

Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells.

Por Lund, L R, Rømer, J, Rønne, E, Ellis, V, Blasi, F, Danø, K
Publicado em 1991

Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.

Por Nielsen, L S, Hansen, J G, Andreasen, P A, Skriver, L, Danø, K, Zeuthen, J
Publicado em 1983

Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.

Por Grøndahl-Hansen, J., Kirkeby, L. T., Ralfkiaer, E., Kristensen, P., Lund, L. R., Danø, K.
Publicado em 1989

Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.

Por Grøndahl-Hansen, J., Ralfkiaer, E., Kirkeby, L. T., Kristensen, P., Lund, L. R., Danø, K.
Publicado em 1991

immunocytochemical localization of urokinase-type plasminogen activator in lewis lung carcinoma

Por Skriver, L, Larsson, LI, Kielberg, V, Nielsen, LS, Andresen, PB, Kristensen, P, Dano, K
Publicado em 1984

Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.

Por Høyer-Hansen, G, Pessara, U, Holm, A, Pass, J, Weidle, U, Danø, K, Behrendt, N
Publicado em 2001

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.

Por Pyke, C., Kristensen, P., Ralfkiaer, E., Grøndahl-Hansen, J., Eriksen, J., Blasi, F., Danø, K.
Publicado em 1991

The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers.

Por Pyke, C., Rømer, J., Kallunki, P., Lund, L. R., Ralfkiaer, E., Danø, K., Tryggvason, K.
Publicado em 1994

The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene.

Por Riccio, A, Lund, L R, Sartorio, R, Lania, A, Andreasen, P A, Danø, K, Blasi, F
Publicado em 1988

Serologic factors in human transplantation.

Por Rapaport, F T, Dausset, J, Hamburger, J, Hume, D M, Dano, K, Williams, G M, Milgrom, F
Publicado em 1967

Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody.

Por Andreasen, P A, Nielsen, L S, Grøndahl-Hansen, J, Skriver, L, Zeuthen, J, Stephens, R W, Danø, K
Publicado em 1984

Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.

Por Andreasen, P A, Pyke, C, Riccio, A, Kristensen, P, Nielsen, L S, Lund, L R, Blasi, F, Danø, K
Publicado em 1987

Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.

Por Quax, P H, Pedersen, N, Masucci, M T, Weening-Verhoeff, E J, Danø, K, Verheijen, J H, Blasi, F
Publicado em 1991

Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.

Por Roldan, A L, Cubellis, M V, Masucci, M T, Behrendt, N, Lund, L R, Danø, K, Appella, E, Blasi, F
Publicado em 1990

Functional overlap between two classes of matrix-degrading proteases in wound healing.

Por Lund, L R, Romer, J, Bugge, T H, Nielsen, B S, Frandsen, T L, Degen, J L, Stephens, R W, Danø, K
Publicado em 1999

Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.

Por Lund, L R, Riccio, A, Andreasen, P A, Nielsen, L S, Kristensen, P, Laiho, M, Saksela, O, Blasi, F, Danø, K
Publicado em 1987